LianBio Sustainability Reports
Following a corporate merger in July 2026, the company changed its name from LianBio to LianMedical and transitioned its operations into a medical device and technology company. It currently focuses on advancing patient access to cutting\-edge global medical technologies and devices across China and other Asia\-Pacific markets, with an emphasis on heart failure treatments. \(https://www.businesswire.com/news/home/20260716287767/en/LianMedical\-Formerly\-Known\-as\-LianBio\-Announces\-Completion\-of\-Merger\-Between\-LianBio\-and\-LianMedical\) [0] [1] [2]
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG00XPQVPF6
1 reports from 2021 to 2021
